Literature DB >> 2290070

Review: systemic absorption of topically applied ocular drugs in humans.

L Salminen1.   

Abstract

Literature on human plasma concentrations after instillation of ocular timolol, levobunolol, atropine, cyclopentolate, scopolamine, phenylephrine, betamethasone and technetium Tc 99m and theories of lacrimal drainage were reviewed. In all studies the eyedrops absorbed rapidly into the systemic circulation. Like the kinetics of the tracer substances in lacrimal scintigraphy, the plasma drug levels showed interindividual variations. Plasma levels of ocular drugs were lower when punctal occlusion was applied, the mechanism, however, could not be explained. Since an early and a late plasma peak was occasionally registered in some subjects in timolol and cyclopentolate studies, it is suggested that systemic absorption of ocular drugs is low during the nasolacrimal passage but occurs during conjunctival and nasal contact.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2290070     DOI: 10.1089/jop.1990.6.243

Source DB:  PubMed          Journal:  J Ocul Pharmacol        ISSN: 8756-3320


  23 in total

Review 1.  Locally administered ocular corticosteroids: benefits and risks.

Authors:  Charles N J McGhee; Simon Dean; Helen Danesh-Meyer
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

Review 2.  Pharmacokinetics of ophthalmic corticosteroids.

Authors:  C N McGhee
Journal:  Br J Ophthalmol       Date:  1992-11       Impact factor: 4.638

3.  Topical brinzolamide and metabolic acidosis.

Authors:  G J Menon; S A Vernon
Journal:  Br J Ophthalmol       Date:  2006-02       Impact factor: 4.638

4.  Intraoperative pulseless electrical activity and acute cardiogenic shock after administration of phenylephrine, epinephrine, and ketamine.

Authors:  Alan D Kaye; Alecia L Sabartinelli; Adam M Kaye; Alan M Holtzman; Paul L Samm
Journal:  Ochsner J       Date:  2010

5.  Simulation of the hydrodynamic conditions of the eye to better reproduce the drug release from hydrogel contact lenses: experiments and modeling.

Authors:  A F R Pimenta; A Valente; J M C Pereira; J C F Pereira; H P Filipe; J L G Mata; R Colaço; B Saramago; A P Serro
Journal:  Drug Deliv Transl Res       Date:  2016-12       Impact factor: 4.617

6.  Comparative study measuring the dilatory effect of a mydriatic device (Mydriasert(®)) versus topical drops.

Authors:  Manuel Saenz-de-Viteri; Patricia Fernández-Robredo; Elisa de Nova; Elvira Bonet-Farriol; Alfonso L Sabater; Javier Zarranz-Ventura; Josemaria Caire; Luis M Sádaba; Angel Salinas-Alamán; Alfredo García-Layana
Journal:  Int J Ophthalmol       Date:  2013-12-18       Impact factor: 1.779

7.  Iatrogenic Cushing syndrome caused by ocular glucocorticoids in a child.

Authors:  Maria Francesca Messina; Mariella Valenzise; Salvatore Aversa; Teresa Arrigo; Filippo De Luca
Journal:  BMJ Case Rep       Date:  2009-05-08

8.  Ocular phenylephrine 2.5% continues to be dangerous.

Authors:  Nauman Ahmed; Waleed Riad; Abdullah Altorpaq; Abdul Zahoor
Journal:  BMJ Case Rep       Date:  2009-03-02

9.  The importance of eyelid closure and nasolacrimal occlusion following the ocular instillation of topical glaucoma medications, and the need for the universal inclusion of one of these techniques in all patient treatments and clinical studies.

Authors:  Allan J Flach
Journal:  Trans Am Ophthalmol Soc       Date:  2008

10.  Nanoemulsion as a potential ophthalmic delivery system for dorzolamide hydrochloride.

Authors:  Hussein O Ammar; H A Salama; M Ghorab; A A Mahmoud
Journal:  AAPS PharmSciTech       Date:  2009-06-18       Impact factor: 3.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.